X-67545316-TGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCA-TGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCA

Variant summary

Our verdict is Benign. The variant received -17 ACMG points: 0P and 17B. BP3BP6_Very_StrongBA1

The NM_000044.6(AR):​c.225_239delGCAGCAGCAGCAGCA​(p.Gln76_Gln80del) variant causes a disruptive inframe deletion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00777 in 997,172 control chromosomes in the GnomAD database, including 184 homozygotes. There are 1,000 hemizygotes in GnomAD. It is difficult to determine the true allele frequency of this variant because it is of type DEL_BIG, and the frequency of such variant types in population databases may be underestimated and unreliable. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.050 ( 169 hom., 403 hem., cov: 0)
Exomes 𝑓: 0.0048 ( 15 hom. 597 hem. )

Consequence

AR
NM_000044.6 disruptive_inframe_deletion

Scores

Not classified

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 1.40

Publications

10 publications found
Variant links:
Genes affected
AR (HGNC:644): (androgen receptor) The androgen receptor gene is more than 90 kb long and codes for a protein that has 3 major functional domains: the N-terminal domain, DNA-binding domain, and androgen-binding domain. The protein functions as a steroid-hormone activated transcription factor. Upon binding the hormone ligand, the receptor dissociates from accessory proteins, translocates into the nucleus, dimerizes, and then stimulates transcription of androgen responsive genes. This gene contains 2 polymorphic trinucleotide repeat segments that encode polyglutamine and polyglycine tracts in the N-terminal transactivation domain of its protein. Expansion of the polyglutamine tract from the normal 9-34 repeats to the pathogenic 38-62 repeats causes spinal bulbar muscular atrophy (SBMA, also known as Kennedy's disease). Mutations in this gene are also associated with complete androgen insensitivity (CAIS). Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jan 2017]
AR Gene-Disease associations (from GenCC):
  • androgen insensitivity syndrome
    Inheritance: XL Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine
  • Kennedy disease
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, ClinGen, G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • partial androgen insensitivity syndrome
    Inheritance: XL Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp
  • complete androgen insensitivity syndrome
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -17 ACMG points.

BP3
Nonframeshift variant in repetitive region in NM_000044.6
BP6
Variant X-67545316-TGCAGCAGCAGCAGCA-T is Benign according to our data. Variant chrX-67545316-TGCAGCAGCAGCAGCA-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 434254.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.131 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ARNM_000044.6 linkc.225_239delGCAGCAGCAGCAGCA p.Gln76_Gln80del disruptive_inframe_deletion Exon 1 of 8 ENST00000374690.9 NP_000035.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ARENST00000374690.9 linkc.225_239delGCAGCAGCAGCAGCA p.Gln76_Gln80del disruptive_inframe_deletion Exon 1 of 8 1 NM_000044.6 ENSP00000363822.3 P10275-1

Frequencies

GnomAD3 genomes
AF:
0.0499
AC:
3322
AN:
66603
Hom.:
169
Cov.:
0
show subpopulations
Gnomad AFR
AF:
0.135
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0308
Gnomad ASJ
AF:
0.0210
Gnomad EAS
AF:
0.0178
Gnomad SAS
AF:
0.0307
Gnomad FIN
AF:
0.00346
Gnomad MID
AF:
0.0131
Gnomad NFE
AF:
0.0136
Gnomad OTH
AF:
0.0549
GnomAD4 exome
AF:
0.00476
AC:
4426
AN:
930582
Hom.:
15
AF XY:
0.00206
AC XY:
597
AN XY:
289264
show subpopulations
African (AFR)
AF:
0.0403
AC:
931
AN:
23129
American (AMR)
AF:
0.00885
AC:
227
AN:
25663
Ashkenazi Jewish (ASJ)
AF:
0.00988
AC:
159
AN:
16091
East Asian (EAS)
AF:
0.0115
AC:
324
AN:
28174
South Asian (SAS)
AF:
0.00807
AC:
358
AN:
44366
European-Finnish (FIN)
AF:
0.00263
AC:
94
AN:
35795
Middle Eastern (MID)
AF:
0.00742
AC:
19
AN:
2560
European-Non Finnish (NFE)
AF:
0.00263
AC:
1882
AN:
715256
Other (OTH)
AF:
0.0109
AC:
432
AN:
39548
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
212
425
637
850
1062
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
30
60
90
120
150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0499
AC:
3324
AN:
66590
Hom.:
169
Cov.:
0
AF XY:
0.0489
AC XY:
403
AN XY:
8238
show subpopulations
African (AFR)
AF:
0.135
AC:
2540
AN:
18774
American (AMR)
AF:
0.0309
AC:
162
AN:
5235
Ashkenazi Jewish (ASJ)
AF:
0.0210
AC:
36
AN:
1714
East Asian (EAS)
AF:
0.0179
AC:
33
AN:
1843
South Asian (SAS)
AF:
0.0300
AC:
27
AN:
901
European-Finnish (FIN)
AF:
0.00346
AC:
7
AN:
2025
Middle Eastern (MID)
AF:
0.0150
AC:
2
AN:
133
European-Non Finnish (NFE)
AF:
0.0136
AC:
473
AN:
34708
Other (OTH)
AF:
0.0543
AC:
44
AN:
811
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.521
Heterozygous variant carriers
0
119
238
358
477
596
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
40
80
120
160
200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000137
Hom.:
237

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Jul 13, 2016
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 16, 2025
Laboratory of Genetics, Children's Clinical University Hospital Latvia
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Androgen resistance syndrome;C0268301:Partial androgen insensitivity syndrome;C0376358:Prostate cancer;C1839259:Kennedy disease;C2678098:Hypospadias 1, X-linked Benign:1
Jul 06, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Androgen resistance syndrome;C1839259:Kennedy disease Benign:1
Jan 23, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
1.4
Mutation Taster
=195/5
polymorphism (auto)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3032358; hg19: chrX-66765158; COSMIC: COSV104424802; API